awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37725909-03FB85DF-F59A-46C0-A2B4-61566DDF51B6
Q37725909-03FB85DF-F59A-46C0-A2B4-61566DDF51B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37725909-03FB85DF-F59A-46C0-A2B4-61566DDF51B6
Fingolimod after natalizumab and the risk of short-term relapse.
P2860
Q37725909-03FB85DF-F59A-46C0-A2B4-61566DDF51B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37725909-03FB85DF-F59A-46C0-A2B4-61566DDF51B6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
700fdebce02aa01080b8e7e350aa8530706fe62b
P2860
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?